Thank you. Just trying to understand the market better. I think it will be a bumpy ride until we get the CD12 results. I firmly believe those results will be THE catalyst needed to get this show on the road. I still don't understand why FDA needs s/c data to approve a MM indication. They are two completely different indications and in my opinion the progressive nature of COVID would dictate the importance of early treatment ie MM. IDK but I'm still on board this ship and looking forward to fantastic CD12 results!
